National and Kapodistrian University of Athens
Σχέση του βήτα υποδοχέα οιστρογόνων με την ευαισθησία κυττάρων καρκίνου του μαστού σε οιστρογόνα, αντιοιστρογόνα και ρετινοειδή
Abstract
dc:descriptionThis study aims at analyzing whether and how Estrogen Receptor beta isoforms ERβ1 and ERβ2 affect the sensitivity of ERα-positive breast cancer cells to estrogens, antiestrogens and retinoids, in order to understand the role of these isoforms in ERα-positive breast cancer prognosis and response to endocrine therapy. We generated clones of ERα-positive MCF-7 breast adenocarcinoma cells that stably express ERβ1 or ERβ2 and compared their response to estrogens, antiestrogens and/or all-trans retinoic acid (atRA) to wild-type MCF-7 cells. We used the ERβ1-selective agonist DPN in combination with the ERα-selective antagonist MPP to determine the effect of activating ERβ1 while keeping ERα blocked. For the opposite effect we developed a pyrazole analogue that behaved as ERα-agonist as well as ERβ1-antagonist but we could not exploit it in our study because it displayed relatively low affinity of binding to ERα and ERβ1. The clones more prominently expressing ERβ1 (Β4) or ERβ2 (D6) were chosen for further studies. The level of expression of ERα in these two clones was ~40% lower compared to MCF-7 cells. Estradiol, the combination of MPP+DPN, hydroxytamoxifen (OHT) and fulvestrant (ICI182,780) arrested B4 cells in G2/M phase, but affected marginally the proliferation of D6 cells. The proliferation of B4 cells was also inhibited by activating ERβ1 while keeping ERα blocked using the combination of MPP+DPN. Additionally MPP+DPN negatively affected the viability of B4 cells. In the presence of low concentration of estradiol D6 cells and, especially, B4 cells displayed lower invasiveness and anchorage-independent colony formation compared to wild-type cells. However, in the presence of ΟΗΤ and ICI182,780, B4 cells showed high invasiveness. The sensitivity of B4 cells was correlated with lack of induction in Chk1 expression, while the increased invasiveness in the presence of OHT and ICI182,780 was correlated with induction of HER2 expression. B4, but not D6, cells also showed increased sensitivity to atRA and its combinations with ΟΗΤ, ICI182,780 or MPP+DPN. These findings are consistent with ERβ1 expression being a favourable prognosis marker in ERα-positive breast cancer and a marker of response to endocrine therapy with antiestrogens or/and retinoids.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Meligova, Aggeliki
- Μελίγκοβα, Αγγελική
Subjects
dc:subject × 16- Οιστρογονικός υποδοχέας βήτα
- Καρκίνος μαστού
- Αντιοιστρογόνα
- Ρετινοειδή
- Αγωνιστές - ανταγωνιστές των ERα και ERβ1
- MCF-7 κύτταρα
- Estrogen receptors beta (β)
- Breast cancer
- Antiestrogens
- Retinoids
- Agonists - antagonists of ERα and ERβ1
- MCF - 7 cells
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25327